Skip to main content
. 2014 Nov 27;6:179–189. doi: 10.2147/BCTT.S71781

Figure 3.

Figure 3

The development in sum of National Cancer Institute Common Terminology Criteria for Adverse Events score.

Notes: Results are expressed by mean values with 95% confidence intervals illustrated by bars. The green bars show BP-C1, the yellow bars show placebo, and the blue bar shows the results after 28 days of follow-up. (A) BP-C1 versus placebo followed by BP-C1 treatment. (B) Extended 64 days of BP-C1 treatment.

Abbreviation: BP-C1, benzene-poly-carboxylic acids complex with cis-diammineplatium (II) dichloride.